Abstract
Mast cells are the central effector cells of acute allergic reactions. Besides histamine which has no significant chemotactic activity of its own, mast cells release other inflammatory mediators into their environment. Several of these factors have neutrophil or eosinophil chemotactic activities, such as leukotriene B4 (LTB4), platelet activating factor (PAF) and neutrophil chemotactic factor (NCF). Enzymes of mast cells can also activate the complement casade, resulting in the production of the potent chemotactic peptide C 5 a. Once inflammatory leukocytes have entered the site of allergic reaction, they can generate the same chemotactic mediators that are produced by mast cells. Chemotactic mediators serve to amplify and perpetuate mast cell-dependent allergic processes, and they induce chronic inflammatory changes and tissue damage in persistent, severe allergic reactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altman LC (1978) Chemotactic lymphokines: a review. In: Gallin JI, Quie PG (eds) Leukocyte Chemotaxis. Raven, New York, pp 267–267
Berrens L (1981) Struktur und Eigenschaften der atopischen Allergene. Hautarzt [Suppl 54] 32: 83–85
Cundell DR, Moodley I, Davies RJ (1984) Properties of a high molecular weight neurophil chemotactic factor, possibly derived from mast cells: evidence for chemokinetic rather than chemotactic activity. Agents Actions 14: 384–387
Clark AF, Gallin JI, Kaplan AP (1975) The selective eosinophil chemotactic activity of histamine. J Exp Med 142: 1462–1476
Czarnetzki BM (1980) Low molecular weight eosinophil chemotactic factor (ECF) production by rat peritoneal mononuclear phagocytes. Immunobiology 157: 62–66
Czarnetzki BM (1981) In vitro generation of eosinophil chemotactic factor (ECF) from human and murine mononuclear phagocytes. Scand J Immunol 13:511 –516
Czarnetzki BM (1983) Increased monocyte Chemotaxis towards leukotriene B4 and platelet activating factor in psoriasis and atopic eczema. Clin Exp Immunol 54:486–492
Czarnetzki BM (1985) Combined effect of chemotactic factors on in vitro leukocyte Chemotaxis. J Invest Dermatol 84: 444 (Abstract)
Czarnetzki BM (1985) Chemotaktische Mediatoren. Allergologie 8: 63–68
Czarnetzki BM, Benveniste J (1981) Effect of synthetic PAF-acether in human neutrophil leukocytes. I. Analysis of the in vitro migration of human neutrophils. Chem Phys Lipids 29: 317–326
Czarnetzki BM, Frosch PJ, Mardin M (1983) Leukotriene B4 and neutrophil-derived eosinophil chemotactic factor: Comparison of their biological activities. Monogr Allergy 18: 193–195
Czarnetzki BM, König W, Lichtenstein LM (1975) Release of eosinophil chemotactic factor from human polymorphonuclear neutrophils by calcium ionophore A 23187 and phagocytosis. Nature 258: 725–726
Czarnetzki BM, Meentken J, Kolde G, Bröcker EB (1985) Morphology of the cellular in-filtrate in delayed pressure urticaria. J Am Acad Dermatol 12:253–259
Czarnetzki BM, Mertensmeier R (1985) In vitro and in vivo Chemotaxis of guinea pig leukocytes towards leukotriene B4 and its co-oxidation products. Prostaglandins 30: 5–12
Czarnetzki BM, Panneck W, Frosch PJ (1980) Inhibitory effect of heparin on leukocyte chemotactic factors. Clin Exp Immunol 39: 526–531
Czarnetzki BM, Zimmermann RE, Fischer N (1981) Further characterization of the neutrophil-derived eosinophil chemotactic factor and comparison to eosinophil chemotactic activity from mast cells. Int Arch Allergy Appl Immunol 66 (S): 172–173
Fink JN (1985) Allergic bronchopulmonary aspergillosis. Chest 87:81 S–84S
Ford-Hutchinson AW (1984) Leukotriene involvement in pathological processes. J Allergy Clin Immunol 74 (S): 437–440
Gorman EE, Morton DR, Hopkins NK, Lin AH (1983) Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis and cyclic AMP accumulation in human polymorphonuclear leukocytes. In: Samuelsson B, Paoletti R, Ramwell P (eds) Advances in prostaglandin, thromboxane, and leukotriene research, vol 12. Raven, New York, pp 57–63
Grabbe J, Czarnetzki BM, Mardin M (1984) Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res 276: 128–130
Ishizaka T, Iwata M, Ishizaka R (1985) Release of histamine and arachidonate from mouse mast cells induced by glycosylation-enhancing factor and bradykinin. J Immunol 134: 1880–1887
Kaliner M (1985) Mast cell mediators and asthma. Chest 87:2 S–5 S
Kownatzki E, Kapp A, Uhrich S (1985) Novel neutrophil chemotactic factor derived from human monocytes. J Invest Dermatol 84: 444 (Abstract)
Lemanske RF, Guthman DA, Kaliner M (1983) The biologic activity of mast cell granules. VII. The effect of anti-neutrophil antibody-induced neutropenia on rat cutaneous late phase reactions. J Immunol 131: 929–933
Mensing H, Czarnetzki BM (1984) Leukotriene B4 induces in vitro fibroblast chemotaxis. J Invest Dermatol 82:9– 12
Nagy L, Lee TH, Kay AB (1982) Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med 306: 497–501
Nathbony SF, Phillips ME, Elias JM, Godfrey HP, Kaplan AP (1983) Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol 71:177– 183
Oertel HL, Kaliner M (1981) The biologic activity of mast cell granules. III. Purification of inflammatory factors of anaphylaxis ( IF-A) responsible for causing late-phase reactions. J Immunol 127: 1398–1402
Rosenbach T, Grabbe J, Moller A, Schwanitz HJ, Czarnetzki BM (1985) Generation of leukotrienes from normal epidermis and their demonstration in cutaneous disease. Br J Dermatol 113 (285) 157–167
Roubin R, Mencia-Huerta JM, Benveniste J (1982) Release of platelet-activating factor ( PAF acether) and leukotrienes C and D from inflammatory macrophages. Eur J Immunol 12: 141–146
Ruzicka T, Simmet T, Peskar BA, Braun-Falco O (1984) Leukotrienes in skin of atopic dermatitis. Lancet 1: 222–223
Samuelsson B (1982) The leukotrienes. An introduction. In: Samuelsson B, Paoletti R (eds) Leukotrienes and other lipoxygenase products. Raven, New York, pp 1–17
Wassermann SI, Soter NA, Center DM, Austen KF (1977) Cold urticaria: recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60: 189–196
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Czarnetzki, B.M. (1986). Chemotactic Factors as Mediators of Allergy. In: Ring, J., Burg, G. (eds) New Trends in Allergy II. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71316-3_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-71316-3_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71318-7
Online ISBN: 978-3-642-71316-3
eBook Packages: Springer Book Archive